FDA Advisors Say More Data Needed for RSV Vaccines in Young Kids

(MedPage Today) -- FDA advisors said that more data are needed to fully understand if there are broader safety concerns related to use of respiratory syncytial virus (RSV) vaccines in young children after an mRNA vaccine trial was halted earlier...